A new study published in The Journal of Nuclear Medicine demonstrates that 213Bi-BPy targeted alpha-therapy can significantly reduce beta-amyloid plaques in the brain, offering a potential new treatment for Alzheimer’s disease.
Hearing aids can slow the metabolic decline in the brains of adults with mild cognitive impairment, particularly in frontal regions important for executive functions, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
A study presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting found FAPI PET/CT more accurate than 18F-FDG PET/CT in staging newly diagnosed breast cancer, restaging about 20% of patients and improving clinical management.
A novel SPECT/CT acquisition method utilizing lead-212 (212Pb) accurately detects radiopharmaceutical biodistribution in prostate cancer patients, potentially revolutionizing treatment by offering precision imaging and increasing global access, as reported in The Journal of Nuclear Medicine.
Read More
PET/MRI can improve diagnostic accuracy for prostate cancer patients and help avoid unnecessary biopsies, according to new research published in the April issue of The Journal of Nuclear Medicine.
Read More
A new radiotheranostic system has the ability to detect and treat ovarian cancer noninvasively, according to new research published in the April issue of The Journal of Nuclear Medicine.
Read More
Researchers have developed a new method for triggering and imaging seizures in epilepsy patients, offering physicians the ability to collect real-time data to tailor epilepsy surgery.
Read More
A new PET radiotracer can differentiate diseased tissues from healthy tissues based on fructose metabolism, according to new research.
Read More